Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study.
Martino R, Caballero MD, Canals C, Simón JA, Solano C, Urbano-Ispízua A, Bargay J, Rayón C, Léon A, Sarrá J, Odriozola J, Conde JG, Sierra J, San Miguel J; ALLOPBSCT Subcommittee of the Spanish Group for Haematopoietic Transplantation (GETH); Group GEL-TAMO. Martino R, et al. Among authors: caballero md. Br J Haematol. 2001 Dec;115(3):653-9. doi: 10.1046/j.1365-2141.2001.03153.x. Br J Haematol. 2001. PMID: 11736950 Free article.
Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation.
Martino R, Caballero MD, Canals C, San Miguel J, Sierra J, Rovira M, Solano C, Bargay J, Pérez-Simon J, León A, Sarrá J, Brunet S, de la Cámara R; alloPBSCT and Infectious/nonifectious Complications Subcommittees of the Grupo Español de Transplante Hematopoyético (GETH). Martino R, et al. Among authors: caballero md. Bone Marrow Transplant. 2001 Aug;28(4):341-7. doi: 10.1038/sj.bmt.1703150. Bone Marrow Transplant. 2001. PMID: 11571505
Severe infections after allogeneic peripheral blood stem cell transplantation: a matched-pair comparison of unmanipulated and CD34+ cell-selected transplantation.
Martino R, Rovira M, Carreras E, Solano C, Jorge S, De La Rubia J, Caballero MD, de Oteyza JP, Zuazu J, Moraleda JM, Ojeda E, Ferrá C, Serrano D, De La Cámara R, Urbano-Ispízua A, Brunet S; AlloPBSCT and Infectious/Non-infectious Complications Subcommittes of the Grupo Español de Trasplante Hematopoyético (GETH). Martino R, et al. Among authors: caballero md. Haematologica. 2001 Oct;86(10):1075-86. Haematologica. 2001. PMID: 11602414
Low transplant-related mortality after second allogeneic peripheral blood stem cell transplant with reduced-intensity conditioning in adult patients who have failed a prior autologous transplant.
Martino R, Caballero MD, de la Serna J, Díez-Martín JL, Urbano-Ispízua A, Tomás JF, Odriozola J, León A, Canals C, San Miguel J, Sierra J. Martino R, et al. Among authors: caballero md. Bone Marrow Transplant. 2002 Jul;30(2):63-8. doi: 10.1038/sj.bmt.1703606. Bone Marrow Transplant. 2002. PMID: 12132043 Clinical Trial.
Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trial.
Gómez-Núñez M, Martino R, Caballero MD, Pérez-Simón JA, Canals C, Mateos MV, Sarrá J, León A, Solano C, Moraleda JM, Urbano-Ispizua A, Besalduch J, Miguel JS, Sierra J. Gómez-Núñez M, et al. Among authors: caballero md. Bone Marrow Transplant. 2004 Mar;33(5):477-82. doi: 10.1038/sj.bmt.1704379. Bone Marrow Transplant. 2004. PMID: 14730333 Clinical Trial.
Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group.
Sureda A, Arranz R, Iriondo A, Carreras E, Lahuerta JJ, García-Conde J, Jarque I, Caballero MD, Ferrà C, López A, García-Laraña J, Cabrera R, Carrera D, Ruiz-Romero MD, León A, Rifón J, Díaz-Mediavilla J, Mataix R, Morey M, Moraleda JM, Altés A, López-Guillermo A, de la Serna J, Fernández-Rañada JM, Sierra J, Conde E; Grupo Español de Linformas/Transplante Autólogo de Médula Osea Spanish Cooperative Group. Sureda A, et al. Among authors: caballero md. J Clin Oncol. 2001 Mar 1;19(5):1395-404. doi: 10.1200/JCO.2001.19.5.1395. J Clin Oncol. 2001. PMID: 11230484
Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens.
Salar A, Sierra J, Gandarillas M, Caballero MD, Marín J, Lahuerta JJ, García-Conde J, Arranz R, León A, Zuazu J, García-Laraña J, López-Guillermo A, Sanz MA, Grañena A, García JC, Conde E; GEL/TAMO Spanish Cooperative Group. Salar A, et al. Among authors: caballero md. Bone Marrow Transplant. 2001 Feb;27(4):405-12. doi: 10.1038/sj.bmt.1702795. Bone Marrow Transplant. 2001. PMID: 11313670
Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcome.
Constans M, Sureda A, Terol MJ, Arranz R, Caballero MD, Iriondo A, Jarque I, Carreras E, Moraleda JM, Carrera D, León A, López A, Albó C, Díaz-Mediavilla J, Fernández-Abellán P, García-Ruiz JC, Hernández-Navarro F, Mataix R, Petit J, Pascual MJ, Rifón J, García-Conde J, Fernández-Rañada JM, Mateos MV, Sierra J, Conde E; GEL/TAMO Cooperative Group. Constans M, et al. Among authors: caballero md. Ann Oncol. 2003 May;14(5):745-51. doi: 10.1093/annonc/mdg206. Ann Oncol. 2003. PMID: 12702529 Free article.
178 results